Catalyst Wire Dossier Catalyst Wire Dossier

Larsucosterol

Larsucosterol · Bausch Health Americas, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Larsucosterol, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) [Phase 3]

See pricing